Literature DB >> 1995602

Alteration of high and low spin equilibrium by a single mutation of amino acid 209 in mouse cytochromes P450.

M Iwasaki1, R Juvonen, R Lindberg, M Negishi.   

Abstract

The identities of the amino acid at position 209 are most critical in determining specific coumarin 7- and steroid 15 alpha-hydroxylase activity in P450coh and P450(15)alpha, respectively. This system, therefore, provides us with an excellent model to study the structural basis for P450 specificity as a monooxygenase. We expressed in Saccharomyces cerevisiae a series of the mutated P450s in which residue 209 was substituted with the various amino acids and characterized the spectral property and hydroxylase activity of these mutated P450s. The positioning of a hydrophobic residue including Phe, Leu, and Val at position 209 resulted in shifting the P450 to the high-spin state, while a charged amino acid such as Lys or Asp produced the low-spin form. Moreover, a P450 with Asn or Gly in this position exhibited spectra indicating a mixture of the high- and low-spin forms. This spin alteration, depending upon the hydrophobicity and size of residue at position 209, indicates that this position is likely to reside close to the sixth axial ligand on the distal surface of the heme in these P450s. This proximity of residue 209 to the ligand may explain the critical role of this residue in determining the hydroxylase specificity and activity of these P450s.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1995602

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Multiple steroid-binding orientations: alteration of regiospecificity of dehydroepiandrosterone 2- and 7-hydroxylase activities of cytochrome P-450 2a-5 by mutation of residue 209.

Authors:  M Iwasaki; D G Davis; T A Darden; L G Pedersen; M Negishi
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

2.  An evaluation of molecular models of the cytochrome P450 Streptomyces griseolus enzymes P450SU1 and P450SU2.

Authors:  J A Braatz; M B Bass; R L Ornstein
Journal:  J Comput Aided Mol Des       Date:  1994-10       Impact factor: 3.686

3.  Expression and induction of drug-metabolizing enzymes in cultured fetal rat hepatocytes.

Authors:  P Kremers; L Roelandt; N Stouvenakers; G Goffinet; J P Thome
Journal:  Cell Biol Toxicol       Date:  1994-04       Impact factor: 6.691

4.  Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.

Authors:  M Iwasaki; R L Lindberg; R O Juvonen; M Negishi
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

5.  Structural alteration of mouse P450coh by mutation of glycine-207 to proline: spin equilibrium, enzyme kinetics, and heat sensitivity.

Authors:  R O Juvonen; M Iwasaki; T Sueyoshi; M Negishi
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

6.  The role of tryptophan 97 of cytochrome P450 BM3 from Bacillus megaterium in catalytic function. Evidence against the 'covalent switching' hypothesis of P-450 electron transfer.

Authors:  A W Munro; K Malarkey; J McKnight; A J Thomson; S M Kelly; N C Price; J G Lindsay; J R Coggins; J S Miles
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

7.  Purification and characterization of an acetone-inducible cytochrome P-450 from hamster liver microsomes.

Authors:  P Puccini; S Menicagli; V Longo; A Santucci; P G Gervasi
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

8.  Sequence of a novel cytochrome CYP2B cDNA coding for a protein which is expressed in a sebaceous gland, but not in the liver.

Authors:  T Friedberg; M A Grassow; B Bartlomowicz-Oesch; P Siegert; M Arand; M Adesnik; F Oesch
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

9.  Phylogenomics of the benzoxazinoid biosynthetic pathway of Poaceae: gene duplications and origin of the Bx cluster.

Authors:  Leslie Dutartre; Frédérique Hilliou; René Feyereisen
Journal:  BMC Evol Biol       Date:  2012-05-11       Impact factor: 3.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.